JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wright, R. A.
Right arrow Articles by Schoepp, D. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wright, R. A.
Right arrow Articles by Schoepp, D. D.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

Vol. 298, Issue 2, 453-460, August 2001

[3H]LY341495 Binding to Group II Metabotropic Glutamate Receptors in Rat Brain

Rebecca A. Wright, M. Brian Arnold, William J. Wheeler, Paul L. Ornstein and Darryle D. Schoepp

Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana

[3H]LY341495 is a highly potent and selective antagonist for group II metabotropic glutamate (mGlu) receptors (mGlu2 and mGlu3), which has been used to label these receptors in cells expressing recombinant receptor subtypes. In this study, we characterized the kinetics, pharmacology, and distribution of [3H]LY341495 binding to mGlu receptors in rat brain tissue. Equilibrium experiments in the rat forebrain demonstrated binding to a single site that was saturable, reversible, and of high affinity (Bmax, 3.9 ± 0.65 pmol/mg of protein, Kd, 0.84 ± 0.11 nM). The relative order of potencies for displacement of [3H]LY341495 by mGlu receptor ligands was LY341495 L-glutamic acid > LY354740 > (2S,1'S,2'S)-2-(carboxycyclopropyl)glycine > 4-(2R,4R)-aminopyrrolidine-2,4-dicarboxylate > (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid > (R,S)-alpha -methyl-4-phosphonophenylglycine > (R,S)3,5-dihydroxyphenylglycine > L-(+)-2-amino-4-phosphonobutyric acid. [3H]LY341495 was not displaced by the selective ionotropic glutamate receptor agonists N-methyl-D-aspartic acid, (R,S)-alpha -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid, or kainate at concentrations up to 1 mM. Comparison of [3H]LY341495 binding in rat brain with recombinant mGlu receptor subtypes demonstrated a very high correlation with mGlu3 receptor binding (r2 = 0.957), a significant, but lower, correlation with mGlu2 receptor binding (r2 = 0.869), but no significant correlation to mGlu8 receptor binding (r2 = 0.284). Regional studies using autoradiography showed a similar distribution of [3H]LY341495 binding to that for group II mGlu receptors previously reported by others using immunocytochemical techniques. These studies indicate that [3H]LY341495 selectively labels group II (mGlu2/3) receptors, but under the conditions used, [3H]LY341495 may bind predominately to mGlu3 receptor populations in the rat forebrain.

0022-3565/01/2982-0453$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
T. Muto, D. Tsuchiya, K. Morikawa, and H. Jingami
Structures of the extracellular regions of the group II/III metabotropic glutamate receptors
PNAS, March 6, 2007; 104(10): 3759 - 3764.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Ohana, O. Barchad, I. Parnas, and H. Parnas
The Metabotropic Glutamate G-protein-coupled Receptors mGluR3 and mGluR1a Are Voltage-sensitive
J. Biol. Chem., August 25, 2006; 281(34): 24204 - 24215.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
H. Schaffhauser, B. A. Rowe, S. Morales, L. E. Chavez-Noriega, R. Yin, C. Jachec, S. P. Rao, G. Bain, A. B. Pinkerton, J.-M. Vernier, et al.
Pharmacological Characterization and Identification of Amino Acids Involved in the Positive Modulation of Metabotropic Glutamate Receptor Subtype 2
Mol. Pharmacol., October 1, 2003; 64(4): 798 - 810.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
J. J. Anderson, S. P. Rao, B. Rowe, D. R. Giracello, G. Holtz, D. F. Chapman, L. Tehrani, M. J. Bradbury, N. D. P. Cosford, and M. A. Varney
[3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine Binding to Metabotropic Glutamate Receptor Subtype 5 in Rodent Brain: In Vitro and in Vivo Characterization
J. Pharmacol. Exp. Ther., December 1, 2002; 303(3): 1044 - 1051.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
D. D. Schoepp
Unveiling the Functions of Presynaptic Metabotropic Glutamate Receptors in the Central Nervous System
J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 12 - 20.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
K. Kassahun, I. S. McIntosh, M. Shou, D. J. Walsh, C. Rodeheffer, D. E. Slaughter, L. A. Geer, R. A. Halpin, N. Agrawal, and A. D. Rodrigues
Role of Human Liver Cytochrome P4503A in the Metabolism of Etoricoxib, a Novel Cyclooxygenase-2 Selective Inhibitor
Drug Metab. Dispos., June 1, 2001; 29(6): 813 - 820.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.